Companies
Employees11-50
Funding~$100M
1 active role
Healthcare AIAI ApplicationAPI / PlatformSeries A$50M-$200M
About
Aureka Biotechnologies is a tech-bio startup that develops a generative AI platform, AuraIDE, to discover and develop antibody therapeutics. The company integrates high-throughput autonomous evolution and single-cell functional screening to design differentiated candidates for cardiometabolic and inflammatory diseases. It operates through a BD/NewCo collaboration model with multinational pharmaceutical companies.
Active Roles
1Key Investors
HongShan, MPCi (Matrix Partners China), BioTrack Capital, 5Y Capital, Qiming Venture Partners, NRL Capital, K2VC, Newlife Capital